BAIT
ANXA1
ANX1, LPC1, RP11-71A24.1
annexin A1
GO Process (12)
GO Function (8)
GO Component (11)
Gene Ontology Biological Process
- alpha-beta T cell differentiation [ISS]
- cellular component movement [TAS]
- cellular response to glucocorticoid stimulus [IDA]
- inflammatory response [TAS]
- keratinocyte differentiation [IDA]
- negative regulation of apoptotic process [TAS]
- negative regulation of interleukin-8 secretion [IMP]
- neutrophil clearance [IMP]
- neutrophil homeostasis [IMP]
- peptide cross-linking [IDA]
- positive regulation of vesicle fusion [IDA]
- signal transduction [TAS]
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
PREY
DAPK3
DLK, ZIP, ZIPK
death-associated protein kinase 3
GO Process (18)
GO Function (8)
GO Component (1)
Gene Ontology Biological Process
- apoptotic process [IDA, IMP]
- cellular response to interferon-gamma [IDA]
- cytokinesis [TAS]
- intracellular signal transduction [IDA]
- negative regulation of translation [IDA]
- positive regulation of apoptotic process [IDA]
- positive regulation of canonical Wnt signaling pathway [IMP]
- protein autophosphorylation [IDA, TAS]
- protein phosphorylation [IDA]
- regulation of actin cytoskeleton reorganization [IDA, TAS]
- regulation of apoptotic process [IBA, TAS]
- regulation of autophagy [TAS]
- regulation of cell motility [TAS]
- regulation of focal adhesion assembly [IDA]
- regulation of mitosis [TAS]
- regulation of mitotic cell cycle [IMP]
- regulation of smooth muscle contraction [TAS]
- regulation of transcription, DNA-templated [TAS]
Gene Ontology Molecular Function
Homo sapiens
Protein-peptide
An interaction is detected between a protein and a peptide derived from an interaction partner. This includes phage display experiments.
Publication
ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers.
Immune checkpoint inhibitors (ICIs) therapy targeting programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) shows promising clinical benefits. However, the relatively low response rate highlights the need to develop an alternative strategy to target PD-1/PD-L1 immune checkpoint. Our study focuses on the role and mechanism of annexin A1 (ANXA1)-derived peptide A11 degrading PD-L1 and the effect of A11 ... [more]
J Immunother Cancer Mar. 01, 2023; 11(3); [Pubmed: 37001908]
Throughput
- High Throughput
Curated By
- BioGRID